There is an intriguing link between differentiation of neuroendocrine cells and tumor progression in prostate cancer. Neuroendocrine differentiation appears to be associated with the androgen-independent state, for which there is currently no successful therapy. However, the role of the neuroendocri
Prostate Cancer and Neuroendocrine Differentiation
✍ Scribed by M. Ö. Tan; Ü. Karaoğlan; B. Çelik; Ö. Ataoğlu; H. Biri; I. Bozkirli
- Book ID
- 110249071
- Publisher
- Springer Netherlands
- Year
- 1999
- Tongue
- English
- Weight
- 719 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0301-1623
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Neuroendocrine differentiation in prostate cancer has received much attention recently because it has been found to be associated with androgen independence and shortened patient survival in some studies. We have investigated the effect of the cytokines interleukin-1 (IL-1), IL-2, and IL-6 on the ex
## BACKGROUND. We studied the extent of neuroendocrine (NE) tumor cell differentiation and its relation to regressive changes in prostate cancer after 3-month hormonal treatment. METHODS. Radical prostatectomy specimens from 103 patients, randomized to 3-month neoadjuvant LH-RH-analogue treatment (
## Background: In the human prostate cancer cell line lncap, interleukin (il)-6 has been shown to regulate both growth and neuroendocrine (ne) differentiation. we recently observed that il-6 mediated growth arrest in lncap by activating stat 3. since differentiation and growth arrest are often asso